Press Release Proformex Debuts Willow, Closing the Information Gap in Life Insurance and Annuities Proformex · Jul 28
Press Release Riot Announces Second Quarter 2026 Earnings Conference Call Riot Platforms, Inc. · Jul 28
Press Release Trevi Therapeutics to Participate in Upcoming August Conferences Trevi Therapeutics, Inc. · Jul 28
Press Release Plus Therapeutics Announces Scientific Presentations and Sponsored Symposium at 2026 SNO/ASCO CNS Metastases Conference Plus Therapeutics Inc. · Jul 28
Press Release ZenaTech’s ZenaDrone Begins Testing Phase for Interceptor P-1 Counter-UAS Drone Platform ZenaTech Inc. · Jul 28
Press Release PMGC Holdings Inc. Announces Strategic Investment in Precision Aerospace & Defense Group and Long-Term Aerospace and Defense Manufacturing Agreement Through A&B Aerospace Inc. PMGC Holdings Inc. · Jul 28
Press Release Kazia Therapeutics Announces the Filing of Provisional Patent for Novel Strategy, Supported by Preclinical Data, to Prevent Metastatic Recurrence in Triple-Negative Breast Cancer Kazia Therapeutics Ltd · Jul 28
Press Release Nasus Pharma Appoints Pharmaceutical Industry Veteran Brendan P. O’Grady as Chief Executive Officer to Lead Strategic Growth Nasus Pharma, Ltd. · Jul 28
Press Release Dyne Therapeutics Announces U.S. FDA Clearance of Investigational New Drug (IND) Application for DYNE-302 in Facioscapulohumeral Muscular Dystrophy (FSHD) Dyne Therapeutics, Inc. · Jul 28
Press Release Palvella Therapeutics to Host Second Quarter 2026 Financial Results and Corporate Update Conference Call on August 4, 2026 Palvella Therapeutics Inc. · Jul 28
Press Release Kiniksa Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Portfolio Execution Kiniksa Pharmaceuticals International, Plc · Jul 28
Press Release China Literature to Report First Half 2026 Financial Results on August 11, 2026 China Literature · Jul 28